Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “rifabutin”

5 pharma patents match "rifabutin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "rifabutin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “rifabutin” · 30,257 patents in full index Clear search

  1. US 11135172

    Rifabutin-based compositions and methods for treating Helicobacter pylori infection

    RedHill Biopharma Ltd. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  2. US 11090326

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  3. US 10143702

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  4. US 9314477

    Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

    RedHill Biopharma Ltd. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  5. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted